Yidong Hong

发表

A PD1 targeted nano-delivery system based on epigenetic alterations of T cell responses in the treatment of gastric cancer

Wei Li, Xueyun Wu, Nan Hu, 2021, Molecular therapy oncolytics.

An Immune-Related Prognostic Signature Predicts Overall Survival in Stomach Adenocarcinomas

Jingzhou Zhang, Xueyuan Wu, H. Lai, 2022, Frontiers in Genetics.

lncRNA OGFRP1 promotes tumor progression by activating the AKT/mTOR pathway in human gastric cancer

Jiaqi Tang, Nan Hu, Yidong Hong, 2021, Aging.

Nanoparticle-Delivered Transforming Growth Factor-β1 siRNA Induces PD-1 against Gastric Cancer by Transforming the Phenotype of the Tumor Immune Microenvironment

Wei Li, Nan Hu, Kangjie Zhou, 2022, Pharmaceuticals.

Efficacy of decitabine-loaded gelatinases-stimuli nanoparticles in overcoming cancer drug resistance is mediated via its enhanced demethylating activity to transcription factor AP-2 epsilon

Wei Li, Nan Hu, Jian Zhang, 2017, Oncotarget.

Strengthening Gastric Cancer Therapy by Trastuzumab-Conjugated Nanoparticles with Simultaneous Encapsulation of Anti-MiR-21 and 5-Fluorouridine

Qin Liu, Rutian Li, Nan Hu, 2017, Cellular Physiology and Biochemistry.

Enhanced antiproliferative activity of antibody-functionalized polymeric nanoparticles for targeted delivery of anti-miR-21 to HER2 positive gastric cancer

Junnian Zheng, Wei Li, Qin Liu, 2017, Oncotarget.

Sh-MARCH8 Inhibits Tumorigenesis via PI3K Pathway in Gastric Cancer

M. Zhuang, Nan Hu, Yidong Hong, 2018, Cellular Physiology and Biochemistry.